Gossamer Bio (GOSS) Current Assets: 2022-2025
Historic Current Assets for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $204.0 million.
- Gossamer Bio's Current Assets fell 40.75% to $204.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $204.0 million, marking a year-over-year decrease of 40.75%. This contributed to the annual value of $309.9 million for FY2024, which is 1.10% up from last year.
- Latest data reveals that Gossamer Bio reported Current Assets of $204.0 million as of Q3 2025, which was down 13.53% from $235.9 million recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's Current Assets registered a high of $370.9 million during Q2 2024, and its lowest value of $173.4 million during Q2 2023.
- For the 3-year period, Gossamer Bio's Current Assets averaged around $275.2 million, with its median value being $275.5 million (2025).
- Its Current Assets has fluctuated over the past 5 years, first soared by 113.93% in 2024, then plummeted by 40.75% in 2025.
- Gossamer Bio's Current Assets (Quarterly) stood at $261.9 million in 2022, then increased by 17.05% to $306.5 million in 2023, then climbed by 1.10% to $309.9 million in 2024, then crashed by 40.75% to $204.0 million in 2025.
- Its last three reported values are $204.0 million in Q3 2025, $235.9 million for Q2 2025, and $275.5 million during Q1 2025.